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SUMMARY
Canine leishmaniosis (CanL) is caused by the parasite Leishmania infantum and is a systemic disease, which can present
with variable clinical signs, and clinicopathological abnormalities. Clinical manifestations can range from subclinical in-
fection to very severe systemic disease. Leishmaniosis is categorized as a neglected tropical disease and the complex
immune responses associated with Leishmania species makes therapeutic treatments and vaccine development challenging
for both dogs and humans. In this review, we summarize innate and adaptive immune responses associated with L. infan-
tum infection in dogs, and we discuss the problems associated with the disease as well as potential solutions and the future
direction of required research to help control the parasite.
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INTRODUCTION
Leishmaniosis is a protozoan disease that is transmit-
ted by the bite of a female phlebotomine sand-fly.
Both human and canine leishmaniosis (CanL) are
categorized as neglected tropical diseases, and are
endemic in the Mediterranean Basin, the Middle
East and in sub-tropical and tropical regions of the
world (Desjeux, 2004). Canine leishmaniosis due to
Leishmania infantum is endemic in approximately
50 countries affecting two major regions; South
America and the Mediterranean region (Baneth
et al. 2008). Prevalence within these regions is vari-
able, largely influenced by climatic and ecological
conditions, which determine the abundance of the
vector (Solano-Gallego et al. 2009). Canine leishma-
niosis spreads quickly and extensively among dog
populations when conditions for transmission become
favourable; that is when there is a high sand-fly
vector and canine-host density (Baneth et al. 2008;
Espejo et al. 2015). Precise prevalence rates are
difficult to compare as over the years different
methods have been used to detect infection. Early
epidemiological studies were based on direct parasito-
logical and serological tests, whereas recent observa-
tions include molecular or cellular immunological
methods (Baneth et al. 2008). However, there is a
positive relationship between the prevalence of disease
in human and canine populations (Marty et al. 1992;
Cunha et al. 1995). A high prevalence of CanL in the
Mediterranean region is present, while human leish-
maniosis is hypoendemic (Farrell, 2002). Increases
in human Leishmania infections in this region have
been linked to an increase in human immunodeficiency
virus cases and co-infection (Abdalmaula et al. 2013),
but there is growing evidence that disease is also
diagnosed in immunocompetent adults (Gramiccia
et al. 2013; Horrillo et al. 2015).
Leishmania has a digenetic lifecycle. Leishmania
metacyclic promastigotes are injected under the
skin of the vertebrate host by the phlebotomine
(sand fly) vector. This form of the parasite is flagel-
lated and they are rapidly engulfed by phagocytic
cells such as neutrophils, dendritic cells and macro-
phages, which are either resident or recruited to the
bite site (Kaye and Scott, 2011). It is believed that
the parasites use neutrophils as a ‘safe hideaway’,
but establish prolific infections in macrophages
where the flagellated promastigotes differentiate
into amastigotes (Faria et al. 2012). These amasti-
gotes then replicate within the parasitophorous
vacuole. Amastigotes multiply by binary division,
causing the host cell to enlarge and eventually
rupture, allowing the released amastigotes to infect
other mononuclear phagocytic cells. Amastigotes
circulating in the blood stream are then available to
be ingested by a sand fly when it takes a blood
meal and the cycle repeats itself (Wakelin, 1996).
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The immune responses to L. infantum infection in
dogs are very variable and can play a key role in con-
trolling the infection. There is a large body of work
that focuses on T-cell mediated immunity but there
is limited data on the importance of innate immune
responses in CanL. The aim of this paper was to
bring together current knowledge of the adaptive
and innate immune responses associated with L. in-
fantum infection in dogs.
CANL
Dogs appear to be the main reservoir host for L. in-
fantum infection, however, in many regions other
canids such as jackals, foxes, wolves and other
mammals, such as hares or black rats, have been
implicated as wild reservoirs (Millan et al. 2014).
It has been suggested that domestic cats should
receive greater attention as a public health risk,
since feline leishmaniosis has been reported in
many countries where canine and human disease is
endemic (Martin-Sanchez et al. 2007; Maia et al.
2008).
Not all dogs exposed to L. infantum develop clin-
ical manifestations and subclinical infections are
more frequent than clinical disease. Therefore, L. in-
fantum in dogs can manifest as chronic subclinical
infection, self-limiting disease or severe illness
(Solano-Gallego et al. 2009). The outcome of
canine L. infantum infection is largely influenced
by the development of the cell-mediated immune
(CMI) response. T lymphocytes play a crucial role
in immunity to leishmaniosis by influencing cyto-
kine production and subsequently interacting with
infected macrophages (Rodriguez-Cortes et al.
2007a).
In dogs, which become sick, clinical features and
the incubation period can vary extensively (Solano-
Gallego et al. 2011). A clinical staging system
based on clinico-pathological abnormalities, clinical
signs and serological status has been proposed in
an attempt to cover the wide spectrum of clinical
manifestations found in CanL (Solano-Gallego
et al. 2009). Based on this system, the correct treat-
ment can be determined and a realistic prognosis
be ascertained. The most common clinical signs
include lymphadenomegaly, cutaneous lesions,
weight loss, anorexia, lethargy and ocular lesions
(Solano-Gallego et al. 2011). Epistaxis is likely to
be the result of several pathogenic factors such as
nasal-mucosal ulceration and thrombocytopathy
(Petanides et al. 2008). An increased number and
size of lymphoid follicles results in lymphadenome-
galy, facilitating palpation of superficial lymph
nodes as a diagnostic measure (Giunchetti et al.
2008). Splenomegaly might also be noted, but is
often mild and difficult to detect. This results from
a disorganization of normal lymphoid tissue and
loss of normal spleen leukocyte diversity (Santana
et al. 2008). Hepatomegaly and liver disease includ-
ing macrophagic and lymphoplasmacytic inflamma-
tion and collagen deposition has also been reported
in cases of CanL (Rallis et al. 2005; Melo et al.
2009), although the principal cause of death attribu-
ted to CanL is severe renal damage (Solano-Gallego
et al. 2009), with glomerulonephritis resulting from
immune complex deposition associated with an
intense humoral response and high parasite loads
(Costa et al. 2003).
IMMUNE VARIATION AS A RISK FACTOR
ASSOCIATED WITH CANL
The precise immune mechanisms responsible for re-
sistance or susceptibility to infection and subsequent
disease are not known for CanL. Nonetheless, it
appears that factors such as breed, immunosuppres-
sion, concomitant disease and nutritional status can
influence the outcome of infection (Miro et al.
2008). Similarly, the presence of ongoing co-
infections with pathogens such as Ehrlichia canis or
Filarias or previous infections appear to be asso-
ciated with more clinical signs and clinicopathologi-
cal abnormalities and disease severity (Mekuzas et al.
2009; Cortese et al. 2011; Tabar et al. 2013). Other
factors that might determine the outcome of infec-
tion includes the virulence of L. infantum parasites
(Martin-Martin et al. 2015), inoculum of parasites,
sand-fly transmission or other routes of transmis-
sion. For example, sand fly salivary proteins can
induce a strong cellular immune response in dogs
(Collin et al. 2009). One study demonstrated that
dogs developed a strong immune response to two
salivary proteins, namely LJL143 and LJM17
from the natural vector sand fly Lutzomyia longipal-
pis. Blood collected from these immunized dogs was
found to contain cells that were producing inter-
feron-gamma (IFN-γ) and subsequently resulted in
the recruitment of immune cells at the inoculation
site, which were found to have an adverse effect on
Leishmania parasites (Collin et al. 2009).
All breeds of dog are potentially susceptible to L.
infantum with factors such as age, gender and pro-
portion of time spent outdoors (especially overnight)
found to influence the likelihood and outcome of in-
fection (Franca-Silva et al. 2003; Zivicnjak et al.
2005; Miranda et al. 2008; Galvez et al. 2010).
However, it has also been established that mongrels
and autochthonous breeds from endemic areas
develop various degrees of resistance to disease
(Solano-Gallego et al. 2000). An example of such a
breed is the Ibizan hound from the island of
Mallorca (Spain). The breed develops very
effective cellular immune responses and rarely pre-
sents with clinical disease (Solano-Gallego et al.
2000). Amongst pedigree dogs, studies have found
that breeds such as Rottweilers, Boxers and
German Shepherds are more susceptible to disease
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than other breeds like Yorkshire Terriers and
Poodles (Ciaramella et al. 1997; Franca-Silva et al.
2003; Miranda et al. 2008). It has also been reported
that Foxhounds may have a genetic susceptibility to
CanL (Duprey et al. 2006). One component of such
genetic variation is the nature of the immune re-
sponse against L. infantum infection (Baneth et al.
2008).
Dog leukocyte antigen (DLA) is part of the major
histocompatibility complex (MHC) in dogs. DLA
has been found to be the main genetic component
associated with canine diabetes. In prone breeds
(including Samoyed, Cairn Terrier and Tibetan
Terrier), the common alleles/haplotypes are DLA-
DBR1*009, DQA1*001 and DQB1*008 (Catchpole
et al. 2008). Quinnell et al. reported a study, which
investigated the relationship between DLA class II
alleles and the course of L. infantum infection in a
group of naturally infected Brazilian dogs. The study
revealed a significant association between the presence
of the allele DLA-DRB1*01502 and susceptibility to
CanL (Quinnell et al. 2003b). The dogs presenting
this allele also had significantly higher anti-
Leishmania IgG levels and were far more likely to be
parasite positive by polymerase chain reaction
(PCR). High IgG levels have been associated with sus-
ceptibility (Quinnell et al. 2003b). Polymorphisms and
mutations of the solute carrier family 11, member a1
gene (Slc11a1) have also been shown to exert a
genetic influence. The gene, also known as natural re-
sistance-associated macrophage protein 1 (NRAMP1),
encodes an ion transporter protein, which is involved
in the control of intraphagosomal replication of para-
sites and in macrophage activation (Blackwell et al.
2001). The haplotype TAG-8-141 has been associated
with Boxer breed predisposition to CanL (Sanchez-
Robert et al. 2005). It is believed that numerous loci
are accountable for the progression of disease as a
result of L. infantum infection in dogs (Quilez et al.
2012). Quilez et al. performed a genome-wide scan
using a dataset of 115 healthy infected and 104
affected Boxer dogs and identified over 126 000
single nucleotide polymorphisms (SNPs) distributed
across the genome. Analysis of these SNPs allowed
the phenotype to be predicted with an accuracy of
∼0·29 in new samples, providing evidence of a signifi-
cant genetic component to CanL within the breed
(Quilez et al. 2012). A recent study using a genome-
wide scan in 20 mixed–breed dogs and 28 controls
identified two candidate loci in chromosomes 1 and
2. Markers discovered were related to notch signaling
(critical for macrophage activity and cluster of differ-
entiation 4 (CD4) T cell differentiation) and IL-2,
IL-15 and IFN-γ expression (Utsunomiya et al.
2015). In addition, polymorphisms in canine toll-like
receptors (TLRs) were characterized following se-
quencing after enrichment of exonic regions (Cusco
et al. 2014). Seven different breeds were studied and
DNA from a total of 335 dogs and 100 wolves were
included in the pools. The results revealed that
TLR5 was the most polymorphic amongst all canine
TLRs (Cusco et al. 2014).
IMMUNE RESPONSES ASSOCIATED WITH CANL
Immune-mediated mechanisms are responsible for
many of the pathological findings in CanL.
Circulating immune complexes and anti-nuclear
antibodies have been detected in dogs with CanL
(Lucena and Ginel, 1998; Margarito et al. 1998;
Smith et al. 2004). Vasculitis induced by immune
complexes activates the complement cascade
(Torrent et al. 2005). This is an important patho-
logical mechanism, which is responsible for tissue
necrosis and for some of dermal, visceral ocular
and renal lesions commonly found in CanL
(Vamvakidis et al. 2000; Torrent et al. 2005;
Baneth et al. 2008). The severity of disease is corre-
lated with high antibody levels and increasing para-
site load (Farrell, 2002). In addition, a study has
revealed that the number of apoptotic cells within
the inflammatory infiltrate is directly related to the
parasitic load and thus the severity of the clinical
picture in infected dogs (Vercosa et al. 2012).
Leishmania is renowned for its ‘silent’ establish-
ment of disease, illustrated by little or no change in
immune response despite parasite proliferation and
dissemination. A silent phase was reported by
Belkaid et al. in mice infected with L. major over a
period of 4–5 weeks before the development of
lesions (Belkaid et al. 2000). This silent establishment
was also reported later in dogs (Santos-Gomes et al.
2002). A low proportion of experimentally infected
dogs expressed specific cytokines in the first 8
months of infection coupled with parasite dissemin-
ation, but without clinical signs of disease (Santos-
Gomes et al. 2002). The authors suggested that this
was the parasite’s ‘silent establishment’ by avoiding
adverse host-cell mediated immunological reactions
(Santos-Gomes et al. 2002).
The following sections of this paper will be about
the immune responses associated with CanL that can
be further broken down into adaptive and innate
immune responses. We will report the adaptive
immune responses first, as these responses have
been covered in greater detail over a longer period
of time compared with innate responses.
ADAPTIVE IMMUNITY
In early studies a clearly defined Th1/Th2 (pro-
inflammatory/anti-inflammatory) dichotomy was
observed in murine leishmaniosis (Sadick et al.
1986; Bretscher et al. 1992; Menon and Bretscher,
1998), however it has since become apparent that
the immune responses associated with both human
and CanL are far more complex. Nonetheless, it is
clear that in both human and experimental animal
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models of the disease, cytokines play a very import-
ant role in influencing the nature of the host immune
response (Cummings et al. 2010). The ability of the
host to control L. infantum infection requires the
generation of CMI responses, which activate host
macrophages, eliminating intracellular parasites. In
both human and experimental models of cutaneous
leishmaniosis (CL), control of the infection is
mediated by the early induction of an IL-12 driven
Th1 immune response along with the production
of IFN-γ by CD4+ T cells (Tripathi et al. 2007).
Conversely, susceptibility to infection and disease
progression in CL is driven predominantly by the
induction of a non-protective IL-4 Th-2-type re-
sponse and the production of Th-2 associated cyto-
kines such as IL-4, IL-10, IL-13 and transforming
growth factor (TGF)-β (Alexander and Bryson,
2005; Tripathi et al. 2007). In experimental models
of murine CL, IL-4 has been shown to play a
crucial role in mediating susceptibility to
Leishmania infection by the down regulation of pro-
tective Th-1 associated cytokines IL-12 and IFN-γ,
therefore inhibiting nitric oxide (NO) production
and eventual parasite killing by macrophages
(Alexander et al. 1999). However, further studies
later demonstrated that the IL-4 mediated exacerba-
tion of CL was dependent upon the particular strain
of Leishmania (Kropf et al. 2003).
Unlike mice, immune responses seen in dogs more
closely resemble those seen in human infections.
Many early CanL studies described protective cell
mediated immune responses that were associated
with the activation of Th1 cells, producing IFN-γ,
IL-2 and TNF-α, and active disease characterized
by mixed Th1/Th2 responses (Carrillo and
Moreno, 2009). However, many of these investiga-
tions were performed on peripheral blood samples
and further studies indicated that the immune
responses to the parasites were in-fact organ
specific (Reis et al. 2009). Th1, Th2 or mixed
Th1/Th2 immune responses were subsequently
observed in different organs of CanL dogs. These
correlated with the absence or presence of clinical
signs and parasite load data (Strauss-Ayali et al.
2007; Travi et al. 2009; Boggiatto et al. 2010).
These findings illustrated that the phenotypic cell
profiles and cytokines involved in immune
responses, in compartments where parasites are
known to replicate, have variable effects on local
parasite control, highlighting the complexity of cel-
lular immune responses in L. infantum infection
(Maia and Campino, 2012). Indeed, cytokine
profiles in different tissues vary greatly. Table 1
shows examples of studies evaluating cytokine
changes in several compartments that have been
evaluated in natural and experimental canine L. in-
fantum infection to date. It is important to highlight
the differences between studies on clinical classifica-
tion of dogs, type of infection, technique employed
for measurement of cytokines and geographical loca-
tion as well as the small sample size of dogs evaluated
in the majority of these studies.
ORGAN SPECIFIC IMMUNE RESPONSES
Lymph node
In popliteal lymph nodes, a balance was observed
between the percentage of IL-10 and TNF-α ex-
pression, which was possibly attributed to an
absence of clinical signs and low parasite loads
(Maia and Campino, 2012). This was similar to
earlier findings where lymph nodes from sub-clinical
dogs had a high expression of pro-inflammatory
cytokines, which was correlated with a low number
of parasites. The authors suggested a role for IL-
10 and TGF-β in disease progression (Alves et al.
2009). In a study by Barbosa et al. they reported
that asymptomatic dogs showed high expression of
genes encoding IL-2 and IL-12 in lymph nodes
(Barbosa et al. 2011). Hosein et al. reported down
regulation of IL-22 with disease progression in an
experimental CanL model (Hosein et al. 2015).
Giunchetti et al. reported that lymph node CD8+
T cells might be involved in a distinct activation
status during CanL which was most likely associated
with immunomodulatory or suppressor cell activity
(Giunchetti et al. 2008). Alexandre-Pires et al.
demonstrated that CD8+ T subpopulations in
lymph nodes from treated dogs were significantly
lower than in asymptomatic non-treated dogs. In
addition, they reported that the CD4+ T cell
subset in lymph nodes of both treated and asymp-
tomatic dogs was significantly higher than that in
control, non-infected dogs (Alexandre-Pires et al.
2010). These findings possibly indicate that an in-
crease in CD8+ T cells is associated with parasite
persistence, whereas CD4+ subpopulation expansion
favours control of the parasite (Alexandre-Pires et al.
2010; Maia and Campino, 2012).
Liver
In the liver of CanL dogs, production of IFN-γ, IL-10
and TGF-β was reported to be high in naturally
infected dogs with no clinical signs of the disease
(Correa et al. 2007). Maia et al. reported similar
findings a few years later. Experimentally infected
dogs expressed these cytokines in addition to inducible
NO synthase (iNOS). However, IL-4 and TNF-α
were not expressed (Maia and Campino, 2012). It
was suggested that the absence of TNF-α in these ex-
perimentally infected dogs might have been associated
with a high level of parasitism (Maia et al. 2010; Maia
andCampino, 2012).Hosein et al. also reported a sign-
ificant down regulation of IL-22 transcription in both
liver and spleen samples when non-infected controls
were compared with L. infantum infected dogs
(Hosein et al. 2015). Nascimento et al. investigated
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Table 1. Examples of studies evaluating cytokine changes in several compartments in natural and experimental canine L. infantum infection
Cytokines/tissues evaluated
Technique employed for
cytokine detection
Clinical status classification and
number of dogs studied
Geographical
location Main findings Reference
IL-10, IL-17A, TNF-α,
IFN-γ/liver, spleen
RT–PCR AD (n= 11) Brazil ↑Parasites and ↓leucocyte infiltration in liver
in SD dogs compared with AD dogs.
(Nascimento
et al. 2015)aSD (n= 10)
Disease progression characterized by ↓ of
Th1 cytokines, iNOS and IL-10 in the
liver and spleen.
IL17A gene transcription positively corre-
lated with iNOS and IFN-γ
IL-6, IL-10, IL-12,TGF-β,
IFN-γ, TNF-α/spleen
ELISA, RT–PCR Seropositive dogs:
Low parasite (n= 46)
Brazil ↓Cytokine transcripts in the high parasite
load group
(Cavalcanti et al.
2015)a
High parasite (n= 42) Negative correlation was found TNF-α,
IFN-γ, IL-12, IL-6; and: IL-10 and TGF-
β and parasite load
IL-10, IFN-γ/serum, spleen ELISA, RT–PCR Seropositive dogs (n= 44) based on
parasite load in the spleen were
divided into Group 1: healthy or
mild disease
Brazil ↑ IFN-γ and TNF-α was associated with
reduced Leishmania burden, whereas
↑ IL-10 was associated with higher
Leishmania load
(Nascimento
et al. 2013)a
Groups 2–4: sick dogs
IL-4, IL-10, TNF-α/spleen,
liver
ELISA, RT–PCR Non-infected (n= 12) Brazil ↑ IL-4, IL-10 and TNF-α in infected dogs (Michelin et al.
2011)aAD(n= 20)
SD (n= 20)
Splenic TNF-α was correlated with parasite
load
IL-4, IL-10, IL-12, IFN-γ,
TNF-α/spleen
RT–PCR Non-infected (n= 7) Brazil ↑ IL-12 production in infected dogs com-
pared with non-infected controls.
(Lage et al.
2007)aAD (n= 8)
OD (n= 10)
SD (n= 12)
IL-10 was positively correlated with disease
progression and parasitism.
Positive correlation between parasitism and
IFN-γ
IL-10, TGF-β1, IFN-γ/
spleen, liver
ELISA AD (n= 15) Brazil ↑TGF-β1 in AD in both liver and spleen. (Correa et al.
2007)aSD (n= 15) ↑IL-10 in both liver and spleen of both
groups.
↑IFN-γ in liver of AD and spleen of SD
IL-17, IL-22/lymph node,
liver, spleen, skin
RT–PCR Non-infected healthy (n= 10) Spain and UK IL-22 transcription down regulation with
disease progression in the liver, spleen and
lymph nodes
(Hosein et al.
2015)bSub-clinical (n= 24)
Sick (n= 7)
No changes of IL-17 with disease
progression
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Table 1. (Cont.)
Cytokines/tissues evaluated
Technique employed for
cytokine detection
Clinical status classification and
number of dogs studied
Geographical
location Main findings Reference
IFN-γ, TNF-α, IL-4, IL-5,
IL-10, IL-18, IL-12p40,
TGF-β/spleen
RT–PCR Non-infected (n= 2)
Experimentally infected (n= 7)
Israel Splenic IFN-γ increased most significantly
of all cytokines following infection.
(Strauss-Ayali
et al. 2007)a,b
Naturally infected (n= 10) No changes in IL-18, IL-12, TNF-α, IL-
10, TGF-β expression were noted during
infection
IFN-γ, TNF-α, TGF-β, IL-
10/lymph node
RT–PCR Non-infected (n= 6) Brazil ↑ IFN-γ and TNF-α along with low parasite
burden in AD.
(Alves et al.
2009)aAD (n= 6)
SD (n= 6) ↑ IL-10 and TGF-β with disease progres-
sion and high parasite load
IL-2, IL-4, IL-12, IFN-γ/
blood, lymph node, bone
marrow
IFA, ELISA Non-infected Healthy (n= 11) Portugal and
Brazil
AD: ↑IL-4 in blood leucocytes and IL-12 in
lymph nodes.
(Barbosa et al.
2011)aAD (n= 13)
SD: ↑IL-2 and IFN-γ in lymph nodes and
bone marrow appeared non-responsive
SD (n= 29)
Treated (n= 11)
IL-10, IFN-γ/L. infantum
stimulated PBMC
ELISA Non-infected (n= 2) USA Disease progression correlates with ↓ IFN-γ
and ↑ IL-10 production
(Boggiatto et al.
2010)aRT–PCR Infected resistant (n= 4)
Infected susceptible (n= 3)
Clinical (n= 4)
IL-6, TNF-α/blood ELISA Healthy (n= 8) Brazil ↑IL-6 was found in infected dogs (de Lima et al.
2007)aInfected (n= 16) No differences in TNF-α production were
reported between groups
IL-4, IL-10, IL-13, IL-18/
blood, bone marrow
Semi-quantitative PCR Non-infected controls (n= 5) Brazil ↑ IFN-γ in infected dogs in both organs (Quinnell et al.
2001)aInfected (n= 27) Infected: ↑ IL-4 in bone marrow
IL-2, IL-4, IL-10, IL-18,
TNF-α, IFN-γ/unstimu-
lated blood, ex vivo stimu-
lated blood
RT–PCR Non-infected (n= 5) Spain Cytokine levels were similar in both groups
of dogs in unstimulated blood.
(Chamizo et al.
2005)bAD (n= 7)
Stimulation with soluble leishmanial
antigen promoted ↑ IL-2 and IFN-γ
IFN-γ, IL-2, IL-12p40,
IL-6, IL-10/stimulated
blood
RT–PCR Non-infected controls (n= 2) Portugal In the first 8 months, low number of dogs
expressing specific cytokines, indicative of
‘silent establishment’ of the parasite
(Santos-Gomes
et al. 2002)bInfected (n= 13)
IL-4, IL-5, IL-10, IL-12,
IL-3,TGF-β1, IFN-γ,
TNF-α/skin
RT–PCR Controls (n= 16) Brazil Mixed cytokine profile observed during
active disease.
(Menezes-Souza
et al. 2011)aAD (n= 10)
OD (n= 10)
SD (n= 15)
An impairment in the expression of both
TNF-α and IFN-γ correlated with the
morbidity of disease
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chemokine and cytokine receptor expression in dogs
naturally infected with L. infantum (Nascimento
et al. 2013). In the liver of symptomatic dogs, a sign-
ificant down regulation was noted for expression
of beta chemokine receptors (CCR), CCR3, CCR4,
CCR5, CCR6 and CCR8 when compared with ex-
pression levels in asymptomatic dogs. These chemo-
kines were also downregulated when symptomatic
dogs were compared with healthy non-infected con-
trols (Nascimento et al. 2013). The authors concluded
that the suppression of these receptors seen in
symptomatic dogs was possibly due to a reduced
migration of immune cells, which would normally
assistwithparasite clearance andgranuloma formation
(Nascimento et al. 2013). Recently, the same authors
documented that the progression of this disease was
characterized not only by the down regulation of T
helper (Th) 1-related cytokines, such as IFN-γ and
TNF-α, but also by the down regulation of genes
encoding interleukin (IL)-17A, inducible NO syn-
thase (iNOS) and IL-10 in the spleen and liver
in symptomatic dogs compared with asymptomatic
dogs (Nascimento et al. 2015).
Spleen
In CanL, there is a strong association with splenic
architecture disruption, often characterized by the
disorganization of normal lymphoid tissue, a loss
of normal spleen leukocyte diversity and eventual
atrophy of the lymphoid tissue (Sanchez et al.
2004). It was reported that in natural infection
there was a positive correlation between the expres-
sion of IL-10 with increasing parasite load and
disease progression (Lage et al. 2007). Conversely,
it has also been reported that no changes in IL-10 ex-
pression were seen in experimentally infected dogs
irrespective of parasite load (Strauss-Ayali et al.
2007). In addition, an association between high
IFN-γ expression and chemokine expression, and
splenic parasitism with disease progression was
reported (Correa et al. 2007). Cavalcanti et al. re-
cently reported that in naturally infected dogs, para-
site load induced splenic architecture breakage,
which resulted in an impairment of both pro-inflam-
matory (IFN-γ, IL-2 and IL-6) and anti-inflamma-
tory cytokines (IL-10 and TGF-β) (Cavalcanti et al.
2015). Michelin et al. measured TNF-α, IL-4 and
IL-10 in the liver and spleen of dogs naturally
infected with L. infantum and reported that all cyto-
kines studied were higher in the spleens of symp-
tomatic dogs compared with asymptomatic or non-
infected controls (Michelin et al. 2011).
Hosein et al. reported an involvement of IL-22 in
the spleen of experimentally infected dogs. In both
early and late stages of infection (6 and 15 months
post infection), IL-22 transcription was significantly
lower when compared with non-infected healthy
control dogs (Hosein et al. 2015). InformationT
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about the involvement of IL-22 in CanL is scarce
but in human studies, it has been described that
lower levels of IL-22 in human visceral leishmanio-
sis (VL) is associated with disease establishment and
it has been suggested that IL-22 plays a complemen-
tary role to Th1 cytokines in the protection against
VL (Pitta et al. 2009).
Nascimento et al. also reported changing chemokine
and chemokine receptor profiles in the spleens of dogs
with varying clinical forms of CanL (Nascimento
et al. 2013). The authors looked at chemokines from
the CC-family chemokine ligand family (CCL), che-
mokine motif ligand (CXCL), CXC chemokine recep-
tors (CXC) and beta chemokine receptors (CCR). A
reduction in expression levels of CCL1, CCL3,
CCL17, CCL20, CCL26, CXCL9, CCR3, CCR4,
CCR6 and CCR8 was reported in the spleens of both
symptomatic and asymptomatic dogs when compared
with non-infected controls. The mRNA levels of
CCL2, CCL5 and CXCL10 were however increased
in the spleens of symptomatic dogs compared with
the levels in the spleens of asymptomatic animals
(Nascimento et al. 2013).
Bone marrow
The progression of Leishmania infection has been
linked with macrophagic inflammation in bone
marrow, accompanied by an increased percentage
of plasma cells and lymphocytes as well as erythroid
hypoplasia (Maia and Campino, 2008). Quinnell
et al. observed an increased accumulation of
TNF-α and IFN-γ in the bone marrow of naturally
infected dogs (Quinnell et al. 2001), and these
findings were also similar to those of Manzillo
et al. who speculated that erythroid hypoplasia
were attributable to bone marrow macrophages pro-
ducing high levels of these cytokines (Manzillo et al.
2006b). Foglia Manzillo et al. evaluated bone
marrow aspirates from 15 naturally infected dogs
with and without clinical signs of disease (Manzillo
et al. 2006b). They reported that the most common
pathological features within the bone marrow of
these dogs were megakaryocytic dysplasia, which
was noted in 10 of the 15 dogs, and erythrophagocy-
tic dysplasia in eight dogs. These features were also
thought to be linked to the increased number of
macrophages found to be producing high levels of
IFN-γ and TNF-α (Manzillo et al. 2006b).
Barbosa et al. reported significantly higher levels of
IL-12 mRNA in the bone marrow of dogs following
treatment with allopurinol and meglumine anti-
moniate compared with healthy, asymptomatic and
symptomatic dogs (Barbosa et al. 2011).
Skin
The skin is crucial for parasite transmission and skin
parasite burdens seem to be the best marker for
transmission potential (Courtenay et al. 2014).
Guarga et al. determined that even seropositive sub-
clinical dogs were infectious to sand-flies through
xenodiagnosis (Guarga et al. 2000). Madeira et al.
looked at skin as a potential parasitological diagnos-
tic tool for CanL and obtained skin samples from the
ear and scapular regions of sero-reactive dogs in the
Belo Horizonte region of Brazil (Madeira et al.
2009). In 61% of the animals tested, isolation of L.
infantum was possible from ear and scapular skin.
The results from the study demonstrated that
intact skin could be a possible detection site for
Leishmania parasites in sero-positive dogs (Madeira
et al. 2009). While the skin is essential for natural
transmission via sand-flies, there is limited data on
the cytokine profiles in this tissue in canine L. infan-
tum infection. Papadogiannakis and Koutinas re-
cently reported a mixed Th1/Th2 cytokine profile
in the dermis of dogs naturally infected with L. in-
fantum. Dogs with clinical signs of CanL were
found to have an overproduction of IL-4, IL-13
and TNF-α in the dermis (Papadogiannakis and
Koutinas, 2015). Menezes-Souza et al. also reported
a mixed cytokine profile in the skin of naturally
infected dogs (Menezes-Souza et al. 2011).
Subclinical dogs were found to express high levels
of IL-13, TNF-α and IFN-γ, and trans-acting
T-cell specific transcription factor GATA-3
(Menezes-Souza et al. 2011). An earlier study by
Brachelente et al. looking at cutaneous lesions in nat-
urally infected dogs revealed that dogs with high
parasite burden had significantly high IL-4 expres-
sion (Brachelente et al. 2005). Most recently,
Hosein et al. reported a marginal significant increase
in the transcription factor forkhead box P3 (FoxP3)
in both subclinical and sick dogs compared with
non-infected controls (Hosein et al. 2015). A study
by Menezes-Souza et al. investigated the chemo-
kines in the skin of dogs with CanL (Menezes-
Souza et al. 2012). It was reported that chemokine
mRNA expression demonstrated enhanced parasite
density and was positively correlated with the ex-
pression of CCL2, CCL4, CCL5, CCL21, and
CXCL8. In contrast, there was a negative correl-
ation between parasite density and CCL24 expres-
sion (Menezes-Souza et al. 2012).
Other tissues
Other groups have investigated the cytokine profiles
present in other tissues such as the brain, jejunum
and colon that were deemed less commonly asso-
ciated with L. infantum infection in dogs
(Figueiredo et al. 2013; Melo et al. 2013).
Figueiredo et al. reported higher levels of IL-10
and TNF-α in the jejunum than the colon of infected
animals, whereas IL-4 was higher in the colon than
the jejunum of infected animals (Figueiredo et al.
2013). In the brains of CanL dogs, Melo et al.
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reported that IL-10, TGF-β and IL-12p40 were
downregulated, while IL-1-β, IFN-γ and TNF-α
were upregulated, however expression levels did
not correlate with parasite load (Melo et al. 2013).
The authors suggested that the differences seen in
the brain were due to the host’s immune response,
regardless of the phase of the disease (Melo et al.
2013).
T CELL MEDIATED IMMUNITY INCLUDING
REGULATORY T LYMPHOCYTES
Clinical CanL has been associated with immuno-
logical changes involving T cells (Barbieri, 2006).
Such changes can be measured as the absence of
delayed type hypersensitivity to Leishmania antigens
(Pinelli et al. 1994; Cardoso et al. 1998), IL-2
production and TNF-α by peripheral blood mono-
nuclear cells in vitro (Pinelli et al. 1995; Santos-
Gomes et al. 2002), and IFN-γ absence and
decreased T-cell numbers in the peripheral blood.
There is also evidence that the absence or decreased
T-cell mediated immunity is due to T-cell exhaus-
tion (Esch et al. 2013). It was demonstrated that ex-
haustion was associated with a significant increase in
the population of T cells with surface expression of
programmed death 1 (PD-1). Blocking PD-1
encouraged the return of CD4+ and CD8+ T cell
function and also resulted in a marked increase in
the production of reactive oxygen species in co-
cultured monocyte derived phagocytes (Esch et al.
2013). Infected macrophages were also lysed by
CD8+ cytotoxic T cells in a histocompatibility
complex-restricted process that can be supressed in
sick dogs with high parasite loads (Pinelli et al.
1994; De Luna et al. 1999). In sub-clinical infection,
the opposite can be seen; low parasitism and the
increased prevalence of CD8+ T lymphocytes (Reis
et al. 2006a). The vast majority of Leishmania
infected dogs present a CMI response, which is
exemplified by strong in vitro lymphocyte prolifer-
ation and positive skin reaction to the intradermal
leishmanin injection (Montenegro test)(Cardoso
et al. 1998; Maia and Campino, 2008). These
responses are eventually blunted with disease pro-
gression in addition to decreased intracellular
killing of amastigotes by neutrophils and macro-
phages (Brandonisio et al. 1996; Baneth et al. 2008).
In sick dogs, the depletion of T lymphocytes in
lymphoid organs becomes falsely compensated B-
cell proliferation and activity (Koutinas and
Koutinas, 2014). This activity, along with the activity
of plasma cells, histiocytes and macrophages, poten-
tially explains the generalized lymphadenomegaly,
splenomegaly and hyperglobulinemia, which have
become clinical hallmarks of this disease (Baneth
et al. 2008; Koutinas and Koutinas, 2014). CanL
associated hyperglobulinemia is detrimental via the
generation of auto-antibodies, anti-histone antibodies
and/or the circulating immune complexes, which are
generated in abundance (Lopez et al. 1996; Cortese
et al. 2009). Renal complications are often a result
of CanL and although there have been high inci-
dences of infection-mediated glomerulonephritis, in-
formation about the pathogenesis of CanL associated
disease is scarce. Esch et al. recently reported that
asymptomatic and symptomatic dogs had increased
glomerular nucleotide-binding domain leucine-rich
repeat-containing-like receptor family, pyrin
domain containing 3 and autophagosome-associated
microtubule-associated protein 1 light chain 3,
which was associated with lesion severity of the glom-
eruli (Esch et al. 2015). Glomerulonephritis was
initiated by complement deposition and IgG, and
the overall findings from the study suggest possible
roles for inflammasome complexes as a cause of glom-
erular damage during L. infantum infection (Esch
et al. 2015).
Regulatory T cells (Tregs), have an important role
in suppression of host immunity in murine (Peters
and Sacks, 2006; Rodrigues et al. 2009) and human
leishmaniosis (Katara et al. 2011; Rai et al. 2012).
Tregs have also been found to play a role in CanL.
Silva et al. evaluated IL-10 and TGF-β production
by Treg cells in the spleen and blood of naturally
infected dogs and correlated these findings with
parasite loads (Silva et al. 2014). The results of this
study revealed an increase in IL-10 production
from Tregs in the spleen of the naturally infected
dogs but no correlation could be determined
between the percentage of spleen Treg cells produ-
cing TGF-β or IL-10 and the parasite load (Silva
et al. 2014). In another study conducted by
Cortese et al., the immune profiles of dogs naturally
infected with L. infantum were investigated (Cortese
et al. 2013). The results revealed a significant in-
crease of Th1 cells, CD8+ and CD3+ T lymphocytes
and a reduced percentage of Treg CD4+, CD3+ and
FoxP3 subsets in infected dogs, irrespective of anti-
body titre (Cortese et al. 2013). Figueiredo et al. also
looked at naturally infected dogs but reported the
expression of Tregs in the jejunum, colon and mes-
enteric lymph nodes (Figueiredo et al. 2014). No
correlation was noted between clinical signs and im-
munological, parasitological findings or histopatho-
logical changes in the gastrointestinal tract.
However, infection with L. infantum resulted in an
increased expression of FoxP3, CD4+, TGF-β, IL-
10, TNF-α and IFN-γ in the colon and jejunum
and a reduction of CD8+ and IL-4 (Figueiredo
et al. 2014). Meanwhile, in the skin of naturally
infected dogs, Menezes-Souza et al. reported a cor-
relation of Tregs GATA-3 and FoxP3 with subclin-
ical infection together with high levels of IL-13,
IFN-γ and TNF-α (Menezes-Souza et al. 2011).
These findings led the authors to conclude that in
subclinical infection or dogs with low levels of skin
parasitism, mixed inflammatory and Treg responses
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could be important for parasite persistence and rep-
lication at low levels and also for the maintenance of
clinical status of these dogs (Menezes-Souza et al.
2011). Hosein et al. have also reported the involve-
ment of Tregs, in particular FoxP3 in CanL
(Hosein et al. 2015). In a recent study, they reported
that FoxP3 was positively correlated with parasite
density in both the liver and skin of sick dogs in an
experimental model of CanL (Hosein et al. 2015).
Further investigations into the role of Tregs in
CanL are still required, but from the information
already available it is clear that Tregs are of import-
ance in this infection.
HUMORAL IMMUNE RESPONSE
In mice, one of the strongest correlations with polar-
ized immunity is the profiling of IgG subclass in
antigen-specific immune response (Day, 2007). In
humans, associations are dependent on clinical
forms of the disease. In localized CL, for example,
there was an association with IgG1, IgG2 and
IgG3, whereas in diffuse cutaneous forms of the
disease the response was dominated by IgG4, IgG1
and IgG2 (Rodriguez et al. 1996). Canine leishma-
niosis is often associated with a marked humoral re-
sponse, which is non-protective and denotes failure
to control the infection. The levels of Leishmania-
specific immunoglobulins are greater in sick dogs
compared with sub-clinical dogs (Palatnik-de-
Sousa et al. 2004). A marked association was seen
between these levels, tissue parasite density and the
clinical status of the animal (Reis et al. 2006b).
Over the years, the levels of canine IgG subclasses;
IgG1 and IgG2, have been extensively researched
in an attempt to establish a correlation between the
type of Th response, the subclass level and the
final clinical outcome of infection (Baneth et al.
2008). Investigations employing monoclonal anti-
bodies to canine IgG1 and IgG2 have displayed a
stable increase in the production of both these sub-
classes during natural and experimental infection
with no indication of a practical use (Quinnell et al.
2003a; Strauss-Ayali et al. 2007). Rodriguez-
Cortes et al. reported that the intensity of L. infan-
tum infection in blood samples was significantly cor-
related with clinical signs and IgG, IgA and IgM
concentrations (Rodriguez-Cortes et al. 2007b).
Understanding humoral responses in CanL dogs is
important to establish a good prognosis and to
enable the best possible treatment
(Papadogiannakis et al. 2010).
INNATE IMMUNE RESPONSES
The components of innate immunity comprise a set
of disease-resistance mechanisms that are not patho-
gen specific but have molecular and cellular compo-
nents that identify classes of molecules specific to
frequently encountered pathogens. Cells associated
with innate immunity such as dendritic cells and
macrophages directly kill pathogenic microbes via
phagocytosis, or they induce the production of cyto-
kines, which facilitate the elimination of pathogens.
The innate immune response instructs the develop-
ment of long lasting pathogen specific adaptive
immune responses (Kumar et al. 2009).
Dendritic cells
Dendritic cells are very important in assisting with
the control of Leishmania infection and impairment
of these cells by the parasite often results in the
onset of disease. However, limited information is
available regarding dendritic cells in canine L. infan-
tum infection. Silva et al. reported that the impair-
ment of follicular dendritic cells, B cell migration,
CXCL13 expression and germinal centre formation
were associated with severe clinical forms of CanL
(Silva et al. 2012). Intradermal injection of leishma-
nin solution induced antigen-specific maturation of
canine dendritic cells in L. infantum dogs (Sacchi
et al. 2006). This had the further effect of inducing
up regulation of surface MHC class II expression.
The results from this study suggested that canine
dendritic cells acted as effector cells in the delayed-
type hypersensitivity reaction seen (Sacchi et al.
2006).
Neutrophils
There is now a large amount of evidence, which sug-
gests that Leishmania parasites are able to infect and
replicate within neutrophils. Polymorphonuclear
leukocytes (PMNs) are manipulated so that the para-
sites use granulocytes as host cells, permitting a pro-
ductive infection. This enables L. major to use the
PMNs as ‘Trojan horses’ before entering the macro-
phages (Laskay et al. 2003). Conversely, De Souza
Carmo et al. showed that amastigote destruction
was observed inside L. amazonensis infected macro-
phages that were co-cultured with neutrophils (de
Souza Carmo et al. 2010). The nitroblue tetrazolium
reduction test (NBT) was investigated as a possible
quick and cost effective assay for evaluation of per-
centage of canine neutrophils and monocytes acti-
vated in peripheral blood (Gomez-Ochoa et al.
2010). The results from the study revealed that
dogs with mild disease or no clinical development
of disease had a significantly higher neutrophil re-
activity (34%) compared with dogs with severe
disease (3·7%) (Gomez-Ochoa et al. 2010).
Neutrophils have been found to have the ability to
de-condense chromatin and eject DNA into the sur-
rounding extracellular environment, resulting in the
trapping and inactivation of pathogens (Abi
Abdallah and Denkers, 2012). This phenomenon is
known as neutrophil extracellular traps (NETs)
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and recent studies have shown that these NETs are
not only important for the destruction of bacterium
and viruses but also in protozoan infections includ-
ing Leishmania, Eimeria, Plasmodium and
Toxoplasma (Baker et al. 2008; Guimaraes-Costa
et al. 2009; Behrendt et al. 2010). It has, however,
been reported that Leishmania parasites have the
ability to utilise these NETs to their advantage
either by facilitating the containment of the parasite
at the site of inoculation (Gabriel et al. 2010) or by
escaping NET mediated killing by activity of the
enzyme 3′-nucleotidase/nuclease (Guimaraes-Costa
et al. 2014). To date, there are no reports of a role
for NETs in CanL.
It has been well established that L. infantum infec-
tion causes oxidative stress of neutrophils (Almeida
et al. 2013b). Oxidative stress is when there is a dis-
ruption in the normal balance between the produc-
tion of reactive oxygen species and antioxidant
defences (Betteridge, 2000). In dogs, oxidative
stress was reported to have occurred in both moder-
ate and severe stages of leishmaniosis. The viability
of neutrophils decreased in the final stages of the
disease and this is thought to have been as a result
of uremia (Almeida et al. 2013b). A similar study
also demonstrated that in moderate disease there
was increased superoxide production but in very
severe stages of disease there was a decrease in super-
oxide production and increased apoptosis, which
was also associated with uremia (Almeida et al.
2013a).
Macrophages
Nitric oxide (NO) production is the last step involved
in the destruction of Leishmania by macrophages.
Nitric oxide is produced by nitric oxide synthase
(NOS), which converts one of the terminal nitrogens
of the guanidine group of L-arginine to NO, produ-
cing citrulline (Marletta et al. 1988). A number of
cytokines have been found to enhance this NO pro-
duction synergistically with IFN-α, potentially facili-
tating parasite control in vivo. IFN-α has been found
to synergize with IFN-γ in the induction of iNOS
and NO production by macrophages in vitro (Green
et al. 1990; Rogers et al. 2009).
Several studies have demonstrated that the main
effector mechanism involved in protection is the
activation of macrophages by IFN-γ and TNF-α,
which kill intracellular amastigotes via the L-
arginine NO pathway. This has been demonstrated
following successful chemotherapy of L. infantum
dogs (Vouldoukis et al. 1996). Anti-leishmanial ac-
tivity and NO production were also detected in a
canine macrophagic cell line infected with L. infan-
tum after incubation with IL-2, IFN-γ and TNF-α
(Pinelli et al. 2000). Inducible NO synthase (iNOS
or NOS2) produces NO and this is known to be
one of the main microbicidal mechanisms in
murine macrophages. Cells stimulated with human
IFN-γ and bacterial lipopolysaccharide (LPS) and
subsequently infected with L. infantum promasti-
gotes showed high levels for fluorescence for NOS2
in their cytoplasm, which was not seen in uninfected
macrophages (Sisto et al. 2001). The authors con-
cluded that in this infection model, canine macro-
phages were able to express NOS2 and that IFN-γ
and LPS have a role in NOS2 production (Sisto
et al. 2001). Zafra et al. investigated the expression
of iNOS by Leishmania infected canine macrophages
and the results from this study revealed that a high
iNOS expression was correlated with a low intracel-
lular amastigote burden (Zafra et al. 2008). The
results from the study suggested that elevated
iNOS expression in canine macrophage was a mech-
anism to control the infection (Zafra et al. 2008).
Meanwhile, Panaro et al. studied dogs naturally
infected with L. infantum in Southern Italy
(Panaro et al. 2008). Blood was taken from each
dog at 4 month intervals and cell culture experi-
ments were set up using macrophages and lympho-
cytes obtained from peripheral blood mononuclear
cells. Supernatants from cultures were assayed with
Griess reagent to detect NO (Panaro et al. 2008).
The results revealed that in the first few months of
infection, NO levels in supernatants with infected
macrophages were higher in dogs that were symp-
tomatic compared with asymptomatic dogs.
However, 8 months after diagnosis, the level of
NO was significantly higher in the asymptomatic
group and in addition, the release of NO signifi-
cantly decreased in cultures with autologous lym-
phocytes in both groups (Panaro et al. 2008).
Holzmuller et al. demonstrated that the co-
incubation of infected macrophages with autologous
lymphocytes from dogs, which were immunized
with purified excreted-Leishmania antigens resulted
in cell death of intracellular amastigotes by NO
mediated apoptosis (Holzmuller et al. 2005). Taken
together, these findings re-inforce the notion that
NO production is important for parasite elimination.
TLRS
It has been widely accepted that in susceptible
dogs, the innate immune system is evaded by the
parasites via a number of mechanisms including re-
modelling of phagosomal compartments and inter-
ference of various signalling pathways (Sacks and
Sher, 2002). In particular, within recent years
there has been a great deal of interest in the involve-
ment of TLRs in Leishmania infection. This has
been extensively studied in both human and
murine models (Kropf et al. 2004a; Liese et al.
2007; Raman et al. 2010; Tuon et al. 2010; Gallego
et al. 2011). However, there is a limited amount of
information about the role that these receptors play
in canine L. infantum infection (Figueiredo et al.
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2013, 2014; Melo et al. 2014a). To date, 10 TLRs
have been characterized in humans with 12 found
to be functional in mice (Kawai and Akira, 2011)
and 10 in dogs (Cusco et al. 2014). TLRs are a
type of pattern recognition receptor. These are
type-1 transmembrane proteins, which are expressed
by cells of the innate immune system and in turn
direct the responses of the adaptive immune
system (Venugopal et al. 2009). TLRs can induce
inflammatory cytokines, type-1 IFN, chemokines
and co-stimulatory molecules. The specificity of
each TLR is dependent on the cytoplasmic adapter
molecules that are associated with the toll- IL 1 re-
ceptor (TIR) domain, known as myeloid differentia-
tion primary response gene 88 (MyD88), Mal
(MyD88 adapter-like) also known as TIR-contain-
ing adapter protein (TIRAP) or toll-like receptor
adapter protein (TRAM) (Medzhitov, 2001; Kawai
and Akira, 2011). The adaptor molecules in turn
provide the necessary structure for the recruitment
and activation of downstream kinases and transcrip-
tion factors that regulate inflammatory responses.
Unlike several other pathogens such as Listeria or
Toxoplasma, there is a marked absence in pro-
inflammatory cytokine induction upon phagocytosis
of Leishmania by macrophages (Carrera et al. 1996).
Adaptive immunity is indispensable for the reso-
lution of infection. However, there is mounting evi-
dence that it is innate mechanisms, which play an
important role in anti-Leishmania defences (Faria
et al. 2012). Early investigations suggesting
Leishmania induces TLR mediated responses
derived from studies using cells lacking MyD88
(Hawn et al. 2002). These experiments revealed
that L. major exposure activated promoter regions
of IL-1α through the MyD88 pathway in macro-
phages (Hawn et al. 2002). Subsequently it was
reported that genetically resistant mice lacking
MyD88 had a high susceptibility to L. major infec-
tion with large non-healing lesions and elevated
Th2 responses. These findings suggested TLR
responses were important for the development of
anti-parasite immunity (Muraille et al. 2003).
TLRs have been found to have important roles in
several canine diseases such as anal furunculosis
(House et al. 2008), osteoarthritis (Kuroki et al.
2010), inflammatory bowel disease (McMahon et al.
2010) and pyometra (Chotimanukul and
Sirivaidyapong, 2011) to name a few. Investigations
into the importance of TLRs in CanL are ongoing,
but at present preliminary. In murine models,
TLR2 has been associated with a protective role in
leishmaniosis. In a L. major murine model, the
TLR2 deficient mice had an increased number of cu-
taneous lesions (deVeer et al. 2003).TLR2 andTLR3
were involved in the phagocytosis of Leishmania
donovani parasites (Flandin et al. 2006). In a human
neutrophil study, it was reported that TLR2 can
directly bind to lipophosphoglycan to promote
signalling events (Becker et al. 2003). In dogs, it
was recently reported that the macrophages derived
from peripheral blood from Leishmania infected
dogs showed a decrease in TLR2 gene expression
compared with healthy non-infected dogs (Melo
et al. 2014b). However, Amorim et al. described
high TLR2 expression in monocytes and granulo-
cytes in Leishmania infected dogs in Brazil. These
dogs were not infectious to sand-flies by xenodiagno-
sis as the skin Leishmania parasite burden was found
to be insufficient (Amorim et al. 2011). More recent-
ly, TLRs in CanLwere studied in the gastrointestinal
tract of infected dogs. This study revealed that the
immunological and parasitological parameters varied
by section of the gastrointestinal tract (Figueiredo
et al. 2013). There was a high parasite load in the
colon, as well as higher frequency and expression of
TLR2, CD11c receptors and IL-4 (Figueiredo et al.
2013). A study by Ordeix et al. recently revealed
that there was a lower expression of TLR2 in skin bi-
opsies from dogs with mild disease (papular derma-
titis) compared with dogs with moderate or severe
disease, supporting an association between TLR2
and the pathogenesis of cutaneous lesions in CanL
(Ordeix et al. 2015). Hosein et al. reported down
regulation of TLR2 transcription in the early stages
of infection in lymph node samples of dogs experi-
mentally infected with L. infantum, followed by up
regulation in subclinical but not sick dogs. Further
evidence of up regulation of TLR2 was revealed in
the liver of both infected groups when compared
with non-infected controls (Hosein et al. 2015).
Overall, TLR2 up regulation seems to be associated
with disease progression in dogs.
TLR3 is reported to be central in the production
of NO and parasite phagocytosis (Flandin et al.
2006). In vitro studies have implied that there is a
possible role for TLR3 in immunity against
Leishmania (Flandin et al. 2006) but in vivo data is
scarce, even in the mouse model. It is believed that
a down regulation in this TLR would favour
disease progression. In a hamster model, Ives et al.
demonstrated that metastasizing L. guyanensis para-
sites have a high Leishmania RNA virus–1(LRV1)
burden, which is recognized by the host TLR3 to
induce pro-inflammatory cytokines and chemokines
and exacerbate disease (Ives et al. 2011). There is
even less information regarding TLR3 in CanL. A
recent study by Turchetti et al. looked at the tran-
scription of cytokines (IL-10, IL-12, TNF-α and
IFN-γ) and innate immunity genes (Nramp1,
Nod-like receptor (NOD)1, NOD2, TLR1, TLR2,
TLR3, TLR4, TLR5, TLR6, TLR7 and TLR9)
in canine macrophages that were resistant or suscep-
tible to intracellular survival of L infantum. The
study revealed that the decreased intracellular sur-
vival of L. infantum in macrophages was associated
with increased production of IFN-γ and TNF-α,
and decreased production of IL-10 (Turchetti
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et al. 2015). This supports the notion that resistance
is associated with a Th1-type response (Pinelli et al.
1994). However, TLR, NLR or Nramp1 appeared
to have no influence on the intracellular survival
of L. infantum (Turchetti et al. 2015). In a recent
experimental CanL study, it was reported that
TLR3 transcription was significantly downregu-
lated with progression of disease in the lymph
nodes when compared with control non-infected
dogs and a tendency of down regulation was also
noted in skin and spleen tissues (Hosein et al.
2015). As the information relating to TLR3 in
CanL is so scarce, further studies would be required
to be able to ascertain if this TLR has an important
role in this infection.
TLR4 has been described as having a protective
role in L. major infections. TLR4 deficient mice had
a diminished parasite load in skin lesions but an
increased parasite survival in host cells, whichwas cor-
related with higher arginase activity (Kropf et al.
2004a). The same group later showed that there was
an increased parasite growth and delayed healing of
cutaneous lesions resulting from a lack of TLR4
(Kropf et al. 2004b). In a L. infantum mouse model
study, it was revealed that L. infantum infection
resulted in increased transcription of TLR4 along
with TLR2 (Cezario et al. 2011). This increased tran-
scription could have been due to an influx of inflam-
matory cells into the spleen, in particular at the
beginning of the infection, and a decrease seen at the
chronic stage of infection could possibly have been
due to partial control of the infection (Cezario et al.
2011). In a recent study looking at naturally infected
dogs, Melo et al. reported increased TLR2 and
TLR4 expression in the spleens of naturally infected
dogs compared with non-infected dogs (Melo et al.
2014a). This elevated expression could indicate that
these TLRs are important for the control of the infec-
tion and they are elevated in an attempt to eliminate
the parasite. More recently, it was reported that sign-
ificant changes were seen with TLR4 transcription in
both the lymph node and spleen in an experimental
model of CanL (Hosein et al. 2015). In both these
tissues, TLR4 was significantly downregulated in
the early (subclinical infection) as well as the late
stages of infection (disease progression) when com-
pared with non-infected controls (Hosein et al.
2015). TLR-4 down regulation appears to be asso-
ciated with disease progression in dogs.
In a L. infantum murine model, cytokine produc-
tion from dendritic cells was dependent on TLR9
(Liese et al. 2007) and in L. major infection, TLR9
was essential for natural killer cell response (Liese
et al. 2007). Down regulation of the TLRs with
disease progression is suggestive of an inhibitory
role where the parasite may be facilitating the onset
of disease by reducing or limiting the transcription
of these TLRs, which would otherwise play a pro-
tective role.
The expression of TLR1, TLR3, TLR4 and
TLR7 were assessed in both TLR2 and TLR9
deficient macrophages (Pandey et al. 2015). The
results of the study revealed that TLR9 was import-
ant for the modulation of TLRs 1, 2 and 3 in a L.
major macrophage model. The TLR9 deficient
macrophages in this study also had reduced CD40
expression and lower levels of TNF-α and IL-12
(Pandey et al. 2015). Tuon et al. looked at TLR9 ex-
pression in patients with cutaneous leishmaniosis
caused by L. braziliensis and found that TLR9 ex-
pression was mainly observed in granulomas. Some
TLR9 positive cells were found in the dermis of
patients. The percentage of cells that expressed
TLR9 was significantly higher in the skin of CL
patients compared with normal skin, but TLR9 ex-
pression was downregulated in keratinocytes of
infected patients (Tuon et al. 2008). In contrast,
Hosein et al. reported significant changes in TLR9
transcription in the spleen and skin of experimental-
ly infected dogs. TLR9 transcription was only upre-
gulated in the early stages of infection in both these
tissues when compared with healthy non-infected
control dogs (Hosein et al. 2015), while TLR9
down regulation was observed in lymph nodes and
skin with disease progression (Hosein et al. 2015).
In another canine study, increased frequency and ex-
pression of TLR9 was associated with a lower para-
site load in the jejunum of L. infantum infected dogs,
whereas the colon showed a higher parasite load
along with an increased frequency and expression
of TLR2 (Figueiredo et al. 2014). Therefore, in
CanL, TLR9 down regulation appears to correlate
with disease progression. Table 2 summarizes the
work to date on TLRs in CanL.
It is evident that there is a very important role for
TLRs in protection against Leishmania infections
including L. infantum infection in dogs. So far,
there is a strong association between overall TLR
down regulation and disease progression, with the
exception of TLR2 in dogs. These parasites have
developed strategies to hijack the innate immune
responses in a survival attempt.
Moreover, several research groups have employed
the strategy of directly targeting TLRs using specific
agonists to elicit protection against several species of
Leishmania including L. major and L. donovani. In
particular, this has been trialled and success reported
for TLRs 2, 4 and 9. Stimulation of these TLRs eli-
cited a protective response and it has been suggested
that antigens stimulating TLRs would be ideal as
potential vaccines (Chandra and Naik, 2008;
Raman et al. 2010; Srivastava et al. 2013; Chandel
et al. 2014; Huang et al. 2015). In Leishmania,
there has already been some progress with the use
of ligands in vaccine development using mice
models, which is promising for future dog studies.
Most recently, Craft et al. reported the use of
topical resiquimod (a synthetic TLR7/8 activating
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Table 2. Summary of published studies evaluating TLRs in canine L. infantum infection
TLRs/tissues evaluated
Technique employed for
TLR detection
Clinical status classification
and number of dogs studied
Geographical
location Main findings Reference
TLR2, TLR3, TLR4,
TLR9/lymph node, liver,
spleen, skin
RT–PCR Healthy non-infected
(n= 10)
Spain and UK ↓TLR3, TLR4 and TLR9 within lymph nodes
with disease progression
(Hosein et al.
2015)a
Sub-clinical (n= 24) ↓TLR4 in the spleen in infected dogs
Sick (n= 7) ↑TLR9 in the skin in early stages of infection
↑TLR2 with disease progression in liver and
lymph nodes
TLR2/skin Immunohistochemistry Healthy non-infected (n= 6) UK and Spain ↓TLR2 was revealed in skin biopsies from dogs
with stage I compared with dogs with stages II
and III
(Ordeix et al.
2015)bStage I, mild disease (n= 11)
Stage II and III, moderate
and severe disease (n= 10)
TLR2, TLR4/PBMC Flow cytometry Healthy controls (n= 60) Brazil ↓ TLR4 in SD (Melo et al.
2014b)bSD (n= 60) No changes observed with TLR2
TLR2, TLR4, TLR9/brain,
choroid plexus, spleen,
lymph node
RT–PCR Healthy non-infected (n= 4)
SD with no neurological
signs (n= 15)
Brazil ↑ TLR2 and TLR9 in the choroid plexus in
infected dogs, whereas this was only the case
for TLR2 in the brain
(Melo et al.
2014a)b
↑ TLR2 and TLR4 in infected dogs in both
spleen and lymph node
TLR2, TLR9/jejunum,
colon
Flow cytometry Non-infected dogs (n= 6) Brazil ↑TLR2 and parasite load in the colon compared
with the jejunum
(Figueiredo
et al. 2013)bAD (n= 12)
SD (n= 12) ↑ TLR9 in the jejunum than the colon
TLR2/blood Flow cytometry SD (n= 48) Brazil ↑ Nitric oxide and, CD11b+ and TLR2 in dogs
with Xeno-/IHQ-
(Amorim et al.
2011)bXeno+/IHQ+ (n= 17)
Xeno-/IHQ− (n= 16)
TLR, toll-like receptor; RT–PCR, reverse transcriptase and real time polymerase chain reaction; PBMC, peripheral blood mononuclear cells; Xeno, xenodiagnosis; IHQ, immuno-
histochemistry; AD, asymptomatic; SD, symptomatic.
a Natural infection.
b Experimental infection.
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molecule), inducing protection against L. infantum
infection in mice (Craft et al. 2014). Topical applica-
tion to the skin of mice prior to, or following system-
ic infection resulted in conferred resistance to future
intravenous challenge and protection that persisted
for as long as 8 weeks after the first topical treatment
(Craft et al. 2014). Mice with existing infections
were also found to have significantly lower visceral
parasite loads following topical resiquimod treat-
ment. Resiquimod was found to increase the traffick-
ing of leukocytes, B-cells, dendritic cells,
macrophages, granulocytes, CD4+ and CD8+
T cells in livers and spleens of the mice (Craft
et al. 2014). In an earlier study, subcutaneous vac-
cination with imiquimod, a TLR7/8 agonist, was
shown to mediate a Th1 response against L. major
antigen, which suppressed Th2 responses following
a challenge infection (Zhang and Matlashewski,
2008). Both studies suggested the use of these com-
pounds as potential vaccine adjuvants for vaccines or
topical preventative and therapeutic agents (Zhang
and Matlashewski, 2008; Craft et al. 2014).
IMMUNOMODULATION: FROM PREVENTION TO
TREATMENT
Effective control of CanL needs to address the verte-
brate host, the vector and the parasite. Life cycle
interruption of Leishmania is currently best achieved
through the use of permethrin based impregnated
dog collars or the topical application of insecticides
(Killick-Kendrick et al. 1997; Courtenay et al.
2009). Spot-on treatment of permethrin was also
found to significantly reduce the incidence of
CanL (Manzillo et al. 2006a). Additional control
measures include spraying homes, animal shelters
and soft furnishings with pyrethroids (Alexander
andMaroli, 2003). Ultimately, the best control strat-
egy would be an effective vaccine. Such a vaccine
would not only reduce the number of CanL cases
but also the incidence in humans (Alvar et al.
2004). Several vaccine candidates have been tested
in the past couple of decades with varying rates of
success in dogs (Foroughi-Parvar and Hatam,
2014). There is no clear cut immune response in
CanL, but it is well established that a Th1 domi-
nated response is the most desired outcome for pro-
tection in the dog (Baneth et al. 2008).
Currently, in Brazil, there is one commercially
available canine vaccine; Leish-Tec® (Hertape
Calier Saude Animal SA). There were previously
two, but Leishmune® (Fort Dodge Animal Health)
is no longer available. Leish-Tec® appeared to par-
tially protect dogs against CanL, but only limited
data from field trials have been reported
(Fernandes et al. 2008). The same authors later
reported that dogs vaccinated with Leish-Tec®
exhibited adverse reactions with greater frequency
and severity compared with dogs vaccinated with
Leishmune® (Fernandes et al. 2014). The toxic
effects of saponin are believed to vary depending
on the compound purity and the dosage used. Both
these vaccines contained saponin as an adjuvant,
but Leishmune® was formulated with purified frac-
tion QS21 (Oliveira-Freitas et al. 2006), known to
have milder toxic effects (Kensil et al. 1991). In
earlier trials, Leishmune® was found to induce a
significant, long-lasting protective effect against
CanL in Phase III clinical trials (da Silva et al.
2000; Borja-Cabrera et al. 2002). Leishmune® was
also proposed to be used as a transmission blocking
vaccine and in immune therapy for dogs already
infected (Borja-Cabrera et al. 2004; Saraiva et al.
2006).
In Europe, the LiESP/QA-21 vaccine was recent-
ly made available. This vaccine is marketed under
the trade name CaniLeish® (Virbac, France) and is
composed of purified excreted-secreted proteins of
L. infantum (LiESP) and adjuvanted with QA-21,
which is a purified fraction of the Quillaja saponaria
saponin (Lemesre et al. 2007). CaniLeish® is
licensed for use with a primary vaccination course
comprising three injections at 3-week intervals sub-
sequently followed by annual booster vaccinations
(Moreno et al. 2012). The same authors were able
to demonstrate in vitro that CaniLeish® elicited a
protective Th1 dominated immune profile, which
lasted for a year after vaccination, and macrophages
were able to reduce the intracellular parasite
burdens in cell culture assays when co-cultured
with autologous lymphocytes (Moreno et al. 2014).
Another study evaluated the preventative efficacy
of a domperidone based treatment programme
against CanL in a high prevalence area (Sabate
et al. 2014). Domperidone is a dopamine D2 recep-
tor antagonist that has been shown to enhance the
innate CMI response, mainly through the reversible
increase of blood prolactin (Gomez-Ochoa et al.
2009). The results from the study demonstrated
that this treatment regime reduced seroconversion
rates in treated healthy dogs in endemic areas of
CanL (Sabate et al. 2014).
TREATMENT OF CLINICAL DISEASE
There are several drugs currently available for the
treatment of CanL. However, while many of these
drugs can result in improved clinical signs, none of
them have the ability to eliminate the infection.
There is also the issue of toxicity and drug resistance
(Noli and Auxilia, 2005). The most common drugs
used for CanL are the meglumine antimoniate, mil-
tefosine and allopurinol. However, in recent years
attempts have been made to use immumodulatory
molecules for treatment of CanL such as the
protein aggregate magnesium-ammonium phospho-
linoleate-palmitoleate anhydride immumo-modula-
tor (P-MAPA) (Santiago et al. 2013) that appears
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to induce TLR2 in human embryonic kidney
(HEK) cells (Favaro et al. 2012) and in canine
macrophages (Melo et al. 2014b). The treatment
with this immumodulator resulted in an improve-
ment in clinical signs and a significant reduction in
parasite load in the skin. Peripheral blood mono-
nuclear cells (PBMC) cultures also showed an in-
crease in IL-2 and IFN-γ and a decrease in IL-10
levels (Santiago et al. 2013). Taken together, the
findings from this study indicated that P-MAPA
has the potential to be used as an immunotherapeutic
drug in CanL (Santiago et al. 2013). Another study
reported the use of a recombinant cysteine protein-
ase from L. infantum (rLdccys1) for immunotherapy
of CanL (Ferreira et al. 2014). Dogs treated with this
proteinase did not display worsening clinical signs,
had a reduction in the splenic parasite load, high
IFN-γ and low IL-10 concentrations in comparison
with control dogs (Ferreira et al. 2014). The findings
of this study illustrated the potential use of rLdccys1
as an immunotherapeutic tool for CanL and war-
rants further investigations (Ferreira et al. 2014).
In conclusion, understanding of CanL caused by
L. infantum is complicated. Visceral dissemination
of the parasites makes sampling from infected
animals difficult. In response experimental in vivo
studies using mice have commonly been undertaken,
although unfortunately these offer a poor reflection
of immune responses associated with L. infantum
in dogs. It is essential that as much information as
possible be gathered from both naturally and experi-
mentally infected dogs to better our understanding
of this disease. Taken together, the findings summar-
ized in this paper illustrate the multi-systemic effect of
L. infantum in dogs. Although a great deal of progress
has been made towards understanding the immune
responses associated with CanL, a vast amount
remains to be determined. A more comprehensive
understanding of both the local and systemic
responses to L. infantum in the dog is needed to be
able to develop more effective treatment regimens
and/or vaccines. Improving the control of the spread
of CanLmight also have a positive impact on reducing
the number of human cases of the disease.
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